<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02080000</url>
  </required_header>
  <id_info>
    <org_study_id>ROC001</org_study_id>
    <nct_id>NCT02080000</nct_id>
  </id_info>
  <brief_title>R-wave Optimisation in Cardiac Resynchronisation Therapy Study</brief_title>
  <official_title>Use of the R-wave to Optimise VV Delay in Heart Failure Patients Treated With Cardiac Resynchronisation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Royal Bournemouth Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Royal Bournemouth Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate whether the use of a simple feature on the 12 lead
      electrocardiogram (ECG) to optimise pacemaker device programming can have clinically relevant
      benefit to patient management. More specifically it is to investigate whether using the
      R-wave in V1 of the surface ECG to guide the timings between left (LV) and right ventricular
      (RV) pacing improves response to Cardiac Resynchronisation Therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Life Score</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>6 minute hall walk distance</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left Ventricular End Systolic Volume Index</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Hospitalisation for any cause</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Hospitalisation for Heart Failure</measure>
    <time_frame>3 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Heart Failure, Systolic</condition>
  <arm_group>
    <arm_group_label>Optimised V-V timing delay</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>V-V timing delay setting on biventricular pacemaker will be optimised guided by size of R-wave on surface ECG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard V-V timing delay</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard settings</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optimisation of V-V timing using R wave on surface ECG</intervention_name>
    <arm_group_label>Optimised V-V timing delay</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard V-V timing settings</intervention_name>
    <arm_group_label>Standard V-V timing delay</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  The patient must have a biventricular pacemaker in situ, implanted for NYHA Class III
             / IV heart failure syndrome with impaired systolic function.

          -  Implantation indication must have included a left ventricular ejection fraction
             measured on transthoracic echo of &lt;35% and either

               -  a QRS duration of &gt;150ms or

               -  a QRS duration of 120 - 149ms with further evidence of dyssynchrony confirmed by
                  echocardiography.

          -  Participants must have &gt;95% true biventricular pacing over the 1 month before
             enrolment and throughout the observation period.

          -  The biventricular paced QRS complex morphology in lead V1 of subject's standard 12
             lead surface ECG must show an R wave height of &lt; 1mm or &lt;20% of the total QRS
             deflection with standard LV offset settings applied.

          -  The subject's standard 12 lead surface ECG must show a right bundle branch block
             pattern in lead V1 during LV only pacing.

          -  The participant must be willing to comply with the protocol requirements including
             travelling to the Royal Bournemouth Hospital for the attendances required for the
             study and intend to have their long term device follow up at the Royal Bournemouth
             Hospital at the time of enrolment.

          -  Provision of informed consent Exclusion criteria

          -  Hypertrophic or restrictive cardiomyopathy

          -  Suspected acute myocarditis

          -  Correctable Valvulopathy

          -  An Acute Coronary Syndrome within the last 3 months

          -  Recent (within the last 3 months) or scheduled coronary revascularisation

          -  Treatment resistant hypertension

          -  Severe obstructive lung disease

          -  Pregnancy at the time of enrolment or a desire to become pregnant during the study
             period

          -  An inability to walk

          -  Reduced life expectancy not associated with cardiovascular disease (less than 1 year)

          -  Unable to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Royal Bournemouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <state>Dorset</state>
        <zip>BH7 7DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 4, 2014</study_first_submitted>
  <study_first_submitted_qc>March 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2014</study_first_posted>
  <last_update_submitted>April 27, 2017</last_update_submitted>
  <last_update_submitted_qc>April 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Cardiac Resynchronisation Therapy</keyword>
  <keyword>Biventricular Pacemaker</keyword>
  <keyword>Optimisation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

